Colorado State University has been recently active in COVID-19 research. We received the virus that causes COVID-19 symptoms at our Fort Collins university from a federally-sponsored source in late February 2020. CSU has deep historical experience with infectious disease research and response. Our work is sponsored by U.S. federal agencies (National Institutes of Health, Department of Defense, U.S. Department of Agriculture, and Centers for Disease Control) large and small pharma and biotech, and nonprofits (CEPI, Gates Foundation, Morris Foundation) focused on understanding and mitigating regional and global chronic and emergent infectious diseases. Because many of the new emergent infectious diseases arise from animals, we have been active in understanding these zoonotic channels of human disease in both fundamental research and its translation across many infectious diseases including AIDS, Ebola hemorrhagic fever, malaria, prion diseases, dengue fever, tuberculosis, and new diseases likeCOVID-19.
All of our work is conducted in specialized biocontainment facilities (BSL3) by a workforce that has focused expertise in safety and security of the work performed at CSU. We are frequently inspected by multiple agencies for these practices (Centers for Disease Control, U.S. Department of Agriculture, and AAALAC) and maintain the highest standards of animal research practices and welfare. For more information on the broad scope of research conducted at CSU, visit www.Research.ColoState.edu.
Colorado State University hosted a COVID-19 panel discussion February 19, featuring university infectious disease researchers.